Roosa Rahunen

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Atrial Fibrillation

Cardiovascular Events

Coronary Artery Bypass Grafting

Top Venues

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Roosa Rahunen, Mikko P Tulppo, Valtteri Rinne, Samuli Lepojärvi, Juha S Perkiömäki, Heikki V Huikuri, Olavi H Ukkola, Heikki V Huikuri, Janne Hukkanen
Liver X Receptor Agonist 4β-Hydroxycholesterol as a Prognostic Factor in Coronary Artery Disease. Journal of the American Heart Association 13 (5) (2024)
Roosa Rahunen, Mikko P Tulppo, Valtteri Rinne, Samuli Lepojärvi, Juha S Perkiömäki, Heikki V Huikuri, Olavi H Ukkola, Heikki V Huikuri, Janne Hukkanen
Liver X Receptor Agonist 4β-Hydroxycholesterol as a Prognostic Factor in Coronary Artery Disease. Journal of the American Heart Association 13 (5) (2024)
Roosa Rahunen, Mikko P Tulppo, Valtteri Rinne, Samuli Lepojärvi, Juha S Perkiömäki, Heikki V Huikuri, Olavi H Ukkola, Heikki V Huikuri, Janne Hukkanen
Liver X Receptor Agonist 4β-Hydroxycholesterol as a Prognostic Factor in Coronary Artery Disease. Journal of the American Heart Association 13 (5) (2024)
Roosa Rahunen, Mikko P Tulppo, Valtteri Rinne, Samuli Lepojärvi, Juha S Perkiömäki, Heikki V Huikuri, Olavi H Ukkola, Heikki V Huikuri, Janne Hukkanen
Liver X Receptor Agonist 4β-Hydroxycholesterol as a Prognostic Factor in Coronary Artery Disease. Journal of the American Heart Association 13 (5) (2024)
Roosa Rahunen, Mikko P Tulppo, Valtteri Rinne, Samuli Lepojärvi, Juha S Perkiömäki, Heikki V Huikuri, Olavi H Ukkola, Heikki V Huikuri, Janne Hukkanen
Liver X Receptor Agonist 4β-Hydroxycholesterol as a Prognostic Factor in Coronary Artery Disease. Journal of the American Heart Association (2024)
Roosa Rahunen, Mikko P Tulppo, Valtteri Rinne, Samuli Lepojärvi, Juha S Perkiömäki, Heikki V Huikuri, Olavi H Ukkola, Heikki V Huikuri, Janne Hukkanen
Liver X Receptor Agonist 4β-Hydroxycholesterol as a Prognostic Factor in Coronary Artery Disease. Journal of the American Heart Association 13 (5) (2024)